This study looks at how many healthcare workers at CHSD have developed antibodies against COVID-19 after the second and third waves of the pandemic and following vaccination. By testing blood samples, we want to understand how well healthcare workers are protected, which work areas might be more at risk, and how immunity changes over time after infection or vaccination.
Study Type
OBSERVATIONAL
Enrollment
76
France
Saint-Denis, France, France
The seroprevalence of SARS-CoV-2 antibodies among healthcare workers at CHSD following COVID-19 vaccination and previous infection.
Time frame: January 2008 - June 2018
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.